TheBlackList Pub

For All Points-Of-The-View.

Santa Rosa urologist and prostate cancer expert Dr. Michael Lazar provides an overview of prostate cancer screening options; says early detection saves lives.

“Knowing the many options for treating prostate cancer is something all men at risk of developing the disease need to be informed about,” says Dr. Michael Lazar of California HIFU. “Most men know about the unpleasant side effects that go along with traditional methods for prostate cancer treatment, including urinary incontinence, bowel and erectile dysfunction. But some of the newer treatment modalities such as HIFU (high-intensity focused ultrasound) which is undertaken at the early stages when damage to surrounding tissue can best be mitigated, eliminates side effects almost completely.”

Why Early Detection is Important

It is estimated that about one man in seven will be diagnosed with prostate cancer during his lifetime. Recent studies have revealed that routine screening in fact does save lives by reducing prostate cancer mortality. How men pursue treatment of an early diagnosis turns out to be a very personal decision, and being well-informed can make all of the difference.

When should men consider being screened?

  • Men 50 and older should talk to a healthcare provider about testing and decide whether it is right for them.
  • For men at higher risk who are age 45 such as African American men or men with a close family member (father, brother, or son) who had prostate cancer before they were 65.
  • Men around age 40 who have more than one close family member who developed prostate cancer at a young age (prior to age 65).

What is PSA?

According to the American Cancer Society prostate-specific antigen (PSA) is a substance made by cells in the prostate gland (both normal cells and cancer cells). PSA is mostly found in semen, but a small amount is also found in the blood. Normal PSA levels under 4 nanograms per milliliter (ng/mL) of blood. The chance of prostate cancer being present goes up as the PSA level goes up. Men with a PSA level between 4 and 10 have about a 1 in 4 chance of having prostate cancer. If the PSA is more than 10, the chance of having prostate cancer is over 50 percent.

Prostate Cancer Therapy Options

There are many treatment options available today including;

  • active surveillance
  • radiation therapy
  • surgery to remove the cancerous gland
  • freezing (cryotherapy)
  • hormonal therapy for very elderly patients
  • high intensity focused ultrasound (HIFU)

“All of these treatment options can be effective under the right circumstances, although many of them have the kind of side effects most men, and certainly all of my patients, would prefer to avoid,” explains Dr. Lazar. “HIFU is perhaps one of the most exciting non-invasive prostate cancer treatment options today – with few to zero side effects in many cases. The key to success with HIFU is early detection, and swift treatment.”

High Intensity Focused Ultrasound (HIFU)

HIFU is a FDA approved precise and targeted therapy that reduces the risk of complications caused by surgery and radiation. HIFU uses ultrasound energy, or sound waves, to destroy specifically targeted areas of tissue. During HIFU, the sound waves pass through healthy tissue without causing damage.

In 2009 researchers examined the effectiveness of HIFU in 31 men who experienced a biochemical recurrence of prostate cancer following external beam radiation. Prior to HIFU, the average PSA among the men was 7.7 ng/ml. Three months after HIFU, about 65 percent reported a PSA of 0.2 ng/ml or less. Of those who reached the six- and nine-month check-ups, about half maintained a PSA at that level.

Dr. Lazar has been successfully treating patients with HIFU since 2007. “HIFU may not be appropriate in every situation, but it is most effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate,” explains Dr. Lazar. “Deciding to have a PSA annually is an important step in taking charge of your own health.”

About Dr. Lazar and California HIFU

Dr. Michael Lazar is the only Northern California physician recognized as a leader in the use of high-intensity focused ultrasound (HIFU) for prostate cancer. He has been successfully treating patients with HIFU since 2007. Dr. Lazar formed California HIFU in order to offer minimally invasive prostate cancer treatment to men with the Sonablate. For more information about HIFU treatment which is now available in San Francisco, or to make an appointment call: (707) 546-5553. Visit us online to learn more: JB Communications 

SANTA ROSA, CA (PRWEB) DECEMBER 31, 2017

Views: 48


Donations Accepted

Discussion Forum

Recruitment underway for study exploring impact of culture and genetics on Hispanics with MS

Started by Bronx Scoop Jun 14. 0 Replies

A study at the Keck School of Medicine of USC focuses on an understudied group of patients to shed light on a little-understood diseaseThe Keck School of Medicine of USC is…Continue

Landmark Alzheimer’s Study Urgently Seeks African American Volunteers - African Americans are twice as likely to develop Alzheimer's disease

Started by KWASI Akyeampong Apr 27. 0 Replies

Study focuses on early detection of Alzheimer’s disease and tracking it over…Continue

Cuban made medication to prevent diabetic foot amputation, heading for the USA

Started by TheBlackList-Publisher Mar 24. 0 Replies

HAVANA TIMES – Cuban and US companies…Continue

© 2018   Created by KWASI Akyeampong.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Rivers APC Hails Rt. Hon. Chibuike Amaechi at 53
= = http://theblacklist.net/